March 13, 2025

FDA Chief Counsel Resigns Two Days In

U.S. FDA's chief counsel resigns amidst controversy surrounding her appointment and connections to mifepristone during the Biden administration.

Reuters

March 12, 2025

Study Finds Wildfires Pose Health Threat for Patients Recovering From Lung Cancer Surgery

A large national study found that patients whose hospital facility was impacted by a wildfire disaster during recovery from lung cancer surgery experienced longer length of stay postoperatively compar...

The ASCO Post

March 12, 2025

CT Scan Radiation: Variability, Risk, and Regulation

New Medicare rules mandate stricter CT scan radiation tracking to reduce exposure risks, standardize dosing, and improve patient safety.

KFF Health News

March 11, 2025

Doctors Never Truly Vacation, Study Reveals

"Organizations should implement strategies to minimize clinical tasks during PTO."

Conexiant

March 10, 2025

Is Red Wine Actually Healthier?

New meta-analysis of 42 studies finds no overall difference in cancer risk between red and white wine consumption, despite long-held beliefs about resveratrol's protective effects; white wine consumption significantly linked to increased skin cancer risk.

Conexiant

March 06, 2025

Can Plasma ctDNA Kinetics Predict Response to Systemic Therapy in Advanced NSCLC?

Based on a systematic review and meta-analysis, plasma circulating tumor DNA (ctDNA) kinetics was found to be predictive of survival outcomes in patients with advanced non–small cell lung cancer (NSCL...

The ASCO Post

March 06, 2025

Early Research Finds Aspirin May Block Cancer Spread by Boosting Immune Response

Preclinical study demonstrates that aspirin may prevent cancer metastasis by inhibiting platelet-produced TXA2, which normally suppresses T-cell immunity against spreading cancer cells.

Conexiant

March 06, 2025

An Estimated 31 Million Americans Borrowed for Medical Bills in 2024

A new West Health-Gallup Survey survey reveals insights into medical debt across all income levels and demographics in the United States.

Conexiant

March 04, 2025

Prophylactic Strategy for Preventing Infusion-Related Reactions With IV Amivantamab in EGFR-Mutated NSCLC

Based on the phase II SKIPPirr trial, the addition of 8 mg of dexamethasone to standard infusion-related reaction prophylaxis appeared to reduce the incidence of such events by approximately threefold...

The ASCO Post